Closed Blood Sampling Device Sales Are Expected To Reach US$ 135.8 Mn By The End Of 2032

Demand for closed blood sampling systems depends upon the global factors associated with rising measures by healthcare facilities towards comprehensive surgical care. Surgical care is a prime and essential practice to effectively manage a varied range of health conditions.

Increasing cases of injury and wound, malignancy, chronic diseases such as cardiovascular diseases and diabetes, obstructed labor, and infections, globally, have accelerated demand for safe and efficient blood sampling techniques, thus posing a positive impact on the growth of the closed blood sampling devices market.

Moreover, lower income economies present a lucrative opportunity for the demand growth of closed blood sampling systems. Market growth is driven by advancements in closed blood sampling systems, allowing contamination-free blood sampling as well as the prevention of needle stick injury to the provider.

Additionally, closed blood sampling systems, as opposed to conventional blood sampling systems, provide a cost-efficient process of sampling, with restricted to no access to the external environment that would otherwise result in sampling errors. Thus, growing number of global surgical procedures due to rise in chronic diseases and infections is associated with the enhancement of the closed blood sampling systems market share.

Want A Detailed Understanding of Market Functioning? Request for a Sample Here –https://www.factmr.com/connectus/sample?flag=S&rep_id=4002

What Factors are Restraining Demand Growth of Closed Blood Sampling Systems?

“Dearth of Skilled Professionals & Less Product Awareness in Developing Nations”

Various restraints associated with the demand growth of closed blood sampling systems include rising global burden of disease, increasing incidence of infectious diseases, especially within low-income economies, and lack of adoption of closed blood sampling systems in these countries as compared to developed countries with established and evolving healthcare infrastructure.

There exists lack of awareness linked to the advantages associated with the adoption of advanced closed systems for blood sampling procedures and the considered cost-effectiveness for routine procedures within hospital settings. Piling onto this factor, lack of presence of professionals skilled with the understanding and guidelines related to advanced closed blood sampling systems and their implementation is another major restraint associated with market growth potential.

There also exists a scarcity of standardized global guidelines for the execution of effective blood sampling. Many countries support recommendations only if they come from a regulatory body.

All these factors thus compile into some major restraints related to the growth in the sales and demand for closed blood sampling devices.

Why is the U.S. a Huge Market for Closed Blood Sampling Systems?

The U.S. closed blood sampling systems market dominated the North American region with 91.2% share in 2021, and is projected to continue experiencing high growth throughout the forecast period.

Growth of this market is driven by rapidly rising awareness regarding safe blood sampling and its advantages in mitigating sample contamination and prevention of infections associated with occupational injuries.

Speak To Research Analyst For Detailed Insights: https://www.factmr.com/connectus/sample?flag=AE&rep_id=4002

Competitive Landscape

Prominent manufacturers of closed blood sampling systems focus on research and development, collaborations, and new product launches, which have emerged as key growth strategies.

  • In January 2021, Inventis, an Italian company founded in 2005 with its headquarters in Padua, which designs and manufactures advanced audiological diagnostics equipment, announced that it has acquired 100% share capital of Synapsys, a French leader in balance diagnostic systems.
  • In June 2018, Interacoustics A/S launched a new Micromedical Orion Rotary Chair for enhanced vestibular assessment.

Similarly, recent developments related to companies manufacturing closed blood sampling products have been tracked by the team at Fact.MR, which are available in the full report.

Key Competitors:

  • ICU Medical, Inc.
  • Smiths Medical, Inc.
  • Edwards Lifesciences Corporation
  • Merit Medical Systems
  • Utah Medical Products, Inc.
  • Elcam Medical
  • CardioMed Supplies Inc.
  • Shenzhen Antmed Co., Ltd.

Key Segments Covered in Closed Blood Sampling Systems Industry Research

Closed Blood Sampling Systems Market by Sampling System:

  • Single-line Blood Sampling Systems
  • Double-Line Blood Sampling Systems
  • Triple-Line Blood Sampling Systems
  • Pressure Transducer/ Monitoring Kits
  • Accessories

Closed Blood Sampling Systems Market by Modality:

  • Arm-mounted Sampling Systems
  • Pole-mounted Sampling Systems

Closed Blood Sampling Systems Market by Age Group:

  • Neonatal/Pediatrics
  • Adults

Closed Blood Sampling Systems Market by End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Blood Banks
  • Others

Closed Blood Sampling Systems Market by Region:

  • North America Closed Blood Sampling Systems Market
  • Latin America Closed Blood Sampling Systems Market
  • Europe Closed Blood Sampling Systems Market
  • South Asia Closed Blood Sampling Systems Market
  • East Asia Closed Blood Sampling Systems Market
  • Oceania Closed Blood Sampling Systems Market
  • MEA Closed Blood Sampling Systems Market

Get Full Access of this Report through our PayPal Payment Optionhttps://www.factmr.com/checkout/4002

 About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Email: sales@factmr.com
Visit Our Website: https://www.factmr.com